Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Ik Kim

Showing results (51-60 of 138) with videos related to

Pageof 14
Sort By:
Cancer Research and Treatment|July 26, 2022
Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence StudySe Ik Kim, Hyunji Lim, Hee Seung Kim, et al.
Journal of Gynecologic Oncology|December 15, 2021
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trialJunsik Park, Myong Cheol Lim, Jae-Kwan Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2024
Comparison of survival outcomes and safety between early and late initiation of niraparib maintenance in newly diagnosed advanced epithelial ovarian cancerSe Ik Kim, Ji Hyun Kim, Eun Young Park, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2026
Association of primary treatment modality and programmed death-ligand 1 expression with survival outcomes in locally advanced human papillomavirus-independent endocervical adenocarcinomaHyunji Lim, Cheol Lee, Ji Won Back, et al.
Genes|August 6, 2021
Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair GenesMin-Hwan Sohn, Se Ik Kim, Jong-Yeon Shin, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Risk of female-specific cancers according to obesity and menopausal status in 2•7 million Korean women: Similar trends between Korean and Western womenIn Sil Park, Se Ik Kim, Youngjin Han, et al.
Journal of Gynecologic Oncology|November 8, 2016
Development of the short version of the Gynecologic Cancer Lymphedema Questionnaire: GCLQ-7Se Ik Kim, Namjoo Kim, Seonjoo Lee, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 13, 2024
Exploring metastasis and recurrence patterns in low-risk grade 3 endometrial cancer: A multicenter retrospective cohort studyAla Aiob, Kwang Beom Lee, Se Ik Kim, et al.
Cancers|April 14, 2025
Innovative qPCR Algorithm Using Platelet-Derived RNA for High-Specificity and Cost-Effective Ovarian Cancer DetectionEunyong Ahn, Se Ik Kim, Sungmin Park, et al.
Gynecologic Oncology|May 26, 2023
Prognostic significance of L1CAM expression in addition to ProMisE in endometrial cancerJunhwan Kim, Se Ik Kim, Nae Ry Kim, et al.
Pageof 14

Showing results (51-60 of 138) with videos related to

Sort By:
Pageof 14
Cancer Research and Treatment|July 26, 2022
Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence StudySe Ik Kim, Hyunji Lim, Hee Seung Kim, et al.
Journal of Gynecologic Oncology|December 15, 2021
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trialJunsik Park, Myong Cheol Lim, Jae-Kwan Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2024
Comparison of survival outcomes and safety between early and late initiation of niraparib maintenance in newly diagnosed advanced epithelial ovarian cancerSe Ik Kim, Ji Hyun Kim, Eun Young Park, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2026
Association of primary treatment modality and programmed death-ligand 1 expression with survival outcomes in locally advanced human papillomavirus-independent endocervical adenocarcinomaHyunji Lim, Cheol Lee, Ji Won Back, et al.
Genes|August 6, 2021
Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair GenesMin-Hwan Sohn, Se Ik Kim, Jong-Yeon Shin, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Risk of female-specific cancers according to obesity and menopausal status in 2•7 million Korean women: Similar trends between Korean and Western womenIn Sil Park, Se Ik Kim, Youngjin Han, et al.
Journal of Gynecologic Oncology|November 8, 2016
Development of the short version of the Gynecologic Cancer Lymphedema Questionnaire: GCLQ-7Se Ik Kim, Namjoo Kim, Seonjoo Lee, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 13, 2024
Exploring metastasis and recurrence patterns in low-risk grade 3 endometrial cancer: A multicenter retrospective cohort studyAla Aiob, Kwang Beom Lee, Se Ik Kim, et al.
Cancers|April 14, 2025
Innovative qPCR Algorithm Using Platelet-Derived RNA for High-Specificity and Cost-Effective Ovarian Cancer DetectionEunyong Ahn, Se Ik Kim, Sungmin Park, et al.
Gynecologic Oncology|May 26, 2023
Prognostic significance of L1CAM expression in addition to ProMisE in endometrial cancerJunhwan Kim, Se Ik Kim, Nae Ry Kim, et al.
Pageof 14